Issue tracker and PRs reopen March 2, 2026. All PRs will be auto-closed until then. Approved contributors can submit PRs after vacation without reapproval. For support, join Discord.
Alkem Laboratories faced a USFDA pre-approval inspection at its Chakan-based facility of Enzene Biosciences, resulting in a Form 483 with six observations. Notably, there were zero observations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results